![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Boceprevir in Addition to Standard of Care Enhanced SVR in Hepatitis C Virus Genotype-1 With Advanced Fibrosis/Cirrhosis: Subgroup Analysis of SPRINT-2 and RESPOND-2 Studies
|
|
|
Reported by Jules Levin EASL 2011 Berlin Germany Marc 30-April 3
Savino Bruno1, John M. Vierling2, Rafael Esteban3, Lisa M. Nyberg4,
Hugo Tanno5, Janice K. Albrecht6, Clifford A. Brass6, Navdeep Boparai6, Vilma Sniukiene6, Margaret Burroughs6
1A.O. Fatebenefratelli e Oftalmico, Milan, Italy, 2Baylor College of Medicine, Houston, TX, USA, 3Vall d'Hebron Hospital, Barcelona, Spain, 4Kaiser Permanente, San Diego, CA, USA, 5Hospital Provincial del Centenario, Rosario, Argentina, 6Merck, Whitehouse Station, NJ, USA.
![croi1.gif](../images/040111/040111-8/croi1.gif)
![croi2.gif](../images/040111/040111-8/croi2.gif)
![croi3.gif](../images/040111/040111-8/croi3.gif)
![croi4.gif](../images/040111/040111-8/croi4.gif)
![croi5.gif](../images/040111/040111-8/croi5.gif)
![croi6.gif](../images/040111/040111-8/croi6.gif)
![croi7.gif](../images/040111/040111-8/croi7.gif)
![croi8.gif](../images/040111/040111-8/croi8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|